{"filing":{"accession_number":"0001171843-26-004972","cik":"0001729214","ticker":"XRTX","company_name":"XORTX Therapeutics Inc.","form":"6-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"f6k_072926.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1729214/000117184326004972/f6k_072926.htm"},"events":[{"id":21357,"run_id":19263,"accession_number":"0001171843-26-004972","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The press release announces the appointment of Depesh Narotam as an independent director of XORTX Therapeutics Inc., effective July 27, 2026. He has also been appointed to the Compensation, Governance and Nominating Committee. This is a clear executive/board appointment disclosure, material to investors as it affects board composition and governance structure.","company_name":"XORTX Therapeutics Inc.","ticker":"XRTX","filing_date":"2026-07-29","form":"6-K","submitted_at":null,"items":[{"id":20983,"accession_number":"0001171843-26-004972","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The press release announces the appointment of Depesh Narotam as an independent director of XORTX Therapeutics Inc., effective July 27, 2026. He has also been appointed to the Compensation, Governance and Nominating Committee. This is a clear executive/board appointment disclosure, material to investors as it affects board composition and governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-29T11:01:37.268187+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20983,"accession_number":"0001171843-26-004972","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The press release announces the appointment of Depesh Narotam as an independent director of XORTX Therapeutics Inc., effective July 27, 2026. He has also been appointed to the Compensation, Governance and Nominating Committee. This is a clear executive/board appointment disclosure, material to investors as it affects board composition and governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-29T11:01:37.268187+00:00","company_name":"XORTX Therapeutics Inc.","ticker":"XRTX","filing_date":"2026-07-29"}]}